Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

Authors	M M van den Heuvel-Eibrink, E A Wiemer, M Kuijpers, R Pieters, P Sonneveld
Journal	Leukemia (Leukemia) Vol. 15 Issue 5 Pg. 855-6 (May 2001) ISSN: 0887-6924 [Print] England
PMID	11368449 (Publication Type: Comment, Letter, Research Support, Non-U.S. Gov't)
Chemical References	Cytarabine Deoxycytidine Kinase
Topics	Cytarabine (metabolism, therapeutic use) Deoxycytidine Kinase (genetics) Drug Resistance, Neoplasm Humans Leukemia, Myeloid, Acute (drug therapy, enzymology, genetics) Mutation Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!